Is this you?
Request access for Maryland Oncology Hematology with your @marylandoncology.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Maryland Oncology Hematology
Unclaimed profileSite Network · Annapolis, Maryland · ~18 sites
Intera lens
ICP 8Lift (cardio sample) 0.07Recruit soph 0.43
Quality Scorecard (1–100)
Overall75Recruit49Ops87Sponsor79Ther88
Performance (observed)
Historical trials
384
Completed
187
Terminated/Withdrawn
44
Completion rate
81%
Active now
137
Phase 2
149
Phase 3
195
Realized enrollment
174,130
First study year
1984
Years active
42
Match confidence
high
Enrollment velocity (inf)
4,146
Therapeutic
Areas
Oncology, Hematology, Breast Cancer, Lung Cancer, Colorectal Cancer
Specialties
Oncology, hematology (breast, lung, colon/rectal, head/neck, gynecologic)
Breadth (conditions)
1,002
Languages
English + Spanish (detected)
States
Maryland
Recruitment (web observed)
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
Capability notes
High - 58 active clinical trials, 18 locations, integrated cancer care network
Relationships
Sponsors
National Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; SWOG Cancer Research Network; Radiation Therapy Oncology Group; ECOG-ACRIN Cancer Research Group; Hoffmann-La Roche
CROs
ICON Clinical Research; MacroGenics; PRA Health Sciences
Partnerships
Sarah Cannon Research Institute
Owner / parent
Part of US Oncology network
Expansion
Y (18+ locations, multi-state)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
gloria.seho-ahiable@usoncology.com
Tech & DCT
eSource
Yes
DCT / decentralized
Y (site mentions)
Recruiting visible
Y
Notes
Large multi-location oncology network (18+ sites across Maryland and D.C.). Connected to US Oncology (major national SMO). CTGOV signal: 13 recruiting trials across 9 Maryland locations. 58 active trials portfolio indicates strong research focus. Recruitment-focused organization. Excellent Intera fit.
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.07Overall75
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.